A tissue-penetrably engineered deoxyribonuclease 1 to prevent nasal polyp formation in chronic rhinosinusitis
Su-Bin Kwak, Roza Khalmuratova, Sang-Jin Kim, Hyun-Woo Shin, Jong-Wan Park · 2025
Read A tissue-penetrably engineered deoxyribonuclease 1 to prevent nasal polyp formation in chronic rhinosinusitis by Su-Bin Kwak, Roza Khalmuratova, Sang-Jin Kim, Hyun-Woo Shin, Jong-Wan Park (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12817691.txt.
Description
Su-Bin Kwak and co-authors engineer an enzyme that chews up the DNA webs driving nasal polyps in stubborn sinus disease. Their study appeared in 2025. In neutrophilic sinusitis, white cells cast sticky DNA traps that damage tissue and seed polyps, and steroids often fail. The team built a version of the natural enzyme DNase1 that penetrates tissue better. In lab tests it dissolved trap-like structures from human cells provoked with bacterial toxin.
In mice bred to model the disease, the enzyme sprayed into the nose cut polyp numbers and trap burden markedly. It matched an injected steroid's effect. The authors propose enzyme therapy as a way around steroid resistance, delivered straight to the tissue that needs it.
Catalog record
| CREATOR | Su-Bin Kwak, Roza Khalmuratova, Sang-Jin Kim, Hyun-Woo Shin, Jong-Wan Park |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |